spaglumic acid

North America

Canada (0)
No result.
United States (0)
No result.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (0)
No result.
Romania (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
NAABAK 49 MG/ML PIC. OFT.,SOL.
1 flac. din PEJD prevazut cu picurator d
-
OTC
-
S01GX03
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
NAABAK 49 MG/ML PIC. OFT.,SOL.
1 flac. din PEJD prevazut cu picurator d
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (0)
No result.
Spain (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
NAAXIA 38 MG/ML eye drops, sol
1 bottle of 10 ml
Y
Rx
ocular
S01GX03
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
NAAXIA 38 MG/ML eye drops, sol
1 bottle of 10 ml
60127
01-10-1994
Product
Pack
SPC
PIL
Company
NAAXIA 38 MG/ML eye drops, sol
1 bottle of 10 ml
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (0)
No result.
Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
NAABAK collyre
-
B
-
S01GX03
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
NAABAK collyre
56998 1
Hauptzulassung
28-07-2006
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.